Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 29.05 CNY -5.03% Market Closed
Market Cap: 15.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Income Statement

Earnings Waterfall
Qingdao Baheal Medical Inc

Revenue
7.5B CNY
Cost of Revenue
-5.2B CNY
Gross Profit
2.3B CNY
Operating Expenses
-1.3B CNY
Operating Income
973m CNY
Other Expenses
-250.5m CNY
Net Income
722.5m CNY

Income Statement
Qingdao Baheal Medical Inc

Rotate your device to view
Income Statement
Currency: CNY
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
5 879
N/A
6 538
+11%
6 797
+4%
7 038
+4%
7 052
+0%
7 286
+3%
7 436
+2%
7 336
-1%
7 510
+2%
7 336
-2%
7 414
+1%
7 486
+1%
7 564
+1%
7 539
0%
7 524
0%
Gross Profit
Cost of Revenue
(4 415)
(4 897)
(5 133)
(5 218)
(5 277)
(5 420)
(5 516)
(5 405)
(5 426)
(5 276)
(5 282)
(5 308)
(5 295)
(5 303)
(5 241)
Gross Profit
1 464
N/A
1 641
+12%
1 664
+1%
1 820
+9%
1 774
-2%
1 866
+5%
1 920
+3%
1 930
+1%
2 084
+8%
2 060
-1%
2 132
+3%
2 178
+2%
2 269
+4%
2 235
-1%
2 283
+2%
Operating Income
Operating Expenses
(1 053)
(1 072)
(1 156)
(1 214)
(1 166)
(1 236)
(1 261)
(1 240)
(1 357)
(1 296)
(1 308)
(1 295)
(1 366)
(1 283)
(1 310)
Selling, General & Administrative
(1 032)
(1 054)
(1 134)
(1 189)
(1 128)
(1 221)
(1 256)
(1 242)
(1 326)
(1 314)
(1 337)
(1 324)
(1 328)
(1 298)
(1 307)
Research & Development
0
0
0
0
0
0
(1)
(2)
(3)
(6)
(11)
(13)
(11)
0
0
Depreciation & Amortization
(21)
(11)
(16)
0
(34)
0
0
0
(43)
0
0
0
(44)
0
0
Other Operating Expenses
(0)
(7)
(6)
(25)
(4)
(15)
(5)
3
15
24
40
42
17
15
(3)
Operating Income
411
N/A
569
+39%
507
-11%
606
+19%
608
+0%
630
+4%
659
+5%
690
+5%
726
+5%
764
+5%
824
+8%
884
+7%
904
+2%
952
+5%
973
+2%
Pre-Tax Income
Interest Income Expense
(43)
(42)
(42)
(49)
(48)
(62)
(56)
(63)
(44)
(54)
(48)
(33)
(36)
6
3
Non-Reccuring Items
0
0
0
0
1
0
1
1
(8)
1
0
0
21
(6)
(6)
Total Other Income
3
2
4
13
4
5
6
(7)
(6)
(6)
(4)
(1)
(14)
(16)
(17)
Pre-Tax Income
371
N/A
529
+43%
469
-11%
570
+22%
565
-1%
573
+1%
611
+7%
621
+2%
669
+8%
705
+5%
771
+9%
849
+10%
874
+3%
935
+7%
952
+2%
Net Income
Tax Provision
(94)
(121)
(119)
(147)
(150)
(153)
(170)
(175)
(183)
(187)
(202)
(215)
(234)
(250)
(239)
Income from Continuing Operations
277
408
350
423
415
420
440
446
485
517
569
634
640
685
713
Income to Minority Interest
(5)
(5)
(2)
(2)
7
5
10
12
17
19
21
18
16
15
9
Net Income (Common)
273
N/A
403
+48%
349
-14%
421
+21%
422
+0%
425
+1%
450
+6%
458
+2%
502
+10%
536
+7%
590
+10%
653
+11%
656
+1%
700
+7%
723
+3%
EPS (Diluted)
0.52
N/A
0.76
+46%
0.83
+9%
0.8
-4%
0.85
+6%
0.8
-6%
0.86
+7%
0.87
+1%
0.96
+10%
1.02
+6%
1.12
+10%
1.24
+11%
1.23
-1%
1.31
+7%
1.33
+2%

See Also

Discover More